These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15730999)

  • 1. Posterior fossa treatment.
    Jones B
    Br J Radiol; 2005 Mar; 78(927):285; author reply 285. PubMed ID: 15730999
    [No Abstract]   [Full Text] [Related]  

  • 2. The challenge of conformal radiotherapy in the curative treatment of medulloblastoma.
    Tarbell NJ; Smith AR; Adams J; Loeffler JS
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):265-6. PubMed ID: 10661330
    [No Abstract]   [Full Text] [Related]  

  • 3. Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy.
    Paulino AC; Narayana A; Mohideen MN; Jeswani S
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):281-6. PubMed ID: 10661333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of conventional, conformal and intensity-modulated coplanar radiotherapy plans for posterior fossa treatment.
    Breen SL; Kehagioglou P; Usher C; Plowman PN
    Br J Radiol; 2004 Sep; 77(921):768-74. PubMed ID: 15447964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In regard to Huang et al.: Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. IJROBP 2002;52:599-605.
    Soomal R; Saran F; Brada M
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):853; author reply 853-4. PubMed ID: 12573781
    [No Abstract]   [Full Text] [Related]  

  • 7. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.
    St Clair WH; Adams JA; Bues M; Fullerton BC; La Shell S; Kooy HM; Loeffler JS; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):727-34. PubMed ID: 14967427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of conformal radiation therapy for medulloblastoma.
    Merchant TE; Happersett L; Finlay JL; Leibel SA
    Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innovations in the treatment of medulloblastoma].
    Carrie C; Martel-Lafay I
    Cancer Radiother; 2000 Nov; 4 Suppl 1():150s-153s. PubMed ID: 11194955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.
    Carrie C; Muracciole X; Gomez F; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Soum F; Baron MH; Clavere P; Chapet S; Gaci Z; Kolodie H; Maingon P; Vie B; Bernier V; Alapetite C; Hoffstetter S; Grill J; Lafay F;
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):711-6. PubMed ID: 15927408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children.
    Yuh GE; Loredo LN; Yonemoto LT; Bush DA; Shahnazi K; Preston W; Slater JM; Slater JD
    Cancer J; 2004; 10(6):386-90. PubMed ID: 15701271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure.
    Silverman CL; Simpson JR
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1869-76. PubMed ID: 6818190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma.
    Fukunaga-Johnson N; Sandler HM; Marsh R; Martel MK
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):77-82. PubMed ID: 9588920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure in children with medulloblastoma treated with 3D conformal radiotherapy.
    Skowrońska-Gardas A; Chojnacka M; Morawska-Kaczyńska M; Perek D; Perek-Polnik M
    Radiother Oncol; 2007 Jul; 84(1):26-33. PubMed ID: 17560676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.
    Huang E; Teh BS; Strother DR; Davis QG; Chiu JK; Lu HH; Carpenter LS; Mai WY; Chintagumpala MM; South M; Grant WH; Butler EB; Woo SY
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):599-605. PubMed ID: 11849779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric medulloblastoma: radiation treatment technique and patterns of failure.
    Miralbell R; Bleher A; Huguenin P; Ries G; Kann R; Mirimanoff RO; Notter M; Nouet P; Bieri S; Thum P; Toussi H
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):523-9. PubMed ID: 9112448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted radiotherapy treatment duration in medulloblastoma.
    Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
    Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol.
    Coles CE; Hoole AC; Harden SV; Burnet NG; Twyman N; Taylor RE; Kortmann RD; Williams MV
    Radiother Oncol; 2003 Nov; 69(2):189-94. PubMed ID: 14643957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.